Tracey Pu, MD

Resident
University of Alabama - Birmingham
Birmingham, Alabama, United States

Tracey Pu is a current PGY-3 general surgery resident at the University of Alabama at Birmingham. Dr. Pu completed her undergraduate training at Wake Forest University with a double major in Studio Art and Biology with Honors. She continued her medical education at Wake Forest School of Medicine. She completed a Surgical Oncology Research Fellowship at the National Cancer Institute/National Institutes of Health (NCI/NIH) from 2022-2025 where under guidance of her mentor, Dr. Jonathan Hernandez, Dr. Pu’s main research interests are leveraging phosphoproteomics mass spectrometry for identification of potential therapeutics and insight into signal dysregulation in relevance to carcinogenesis in gastroenteropancreatic neuroendocrine tumors and adrenocortical carcinoma. Dr. Pu is also interested in clinical research regarding health care equity for surgical oncology patients and serves on multiple national committees including the American College of Surgeons Commission on Cancer, the Annals of Surgical Oncology social media committee, the Society for Surgery of the Alimentary Tract (SSAT)’s Public Policy and Advocacy Committee, SSAT’s Communications Committee, and the Association of Women Surgeons' Resident and Fellows Committee.

Presentation(s):

• QS8. High State-Level Social Vulnerability is Associated with Decreased Receipt of CRS/HIPEC in Non-White Appendiceal Adenocarcinoma Patients

  Thursday, March 5, 2026
  10:19 AM - 10:23 AM MST

• P78. Casein kinase II inhibition with proteosome inhibition demonstrates therapeutic potential in gastroenteropancreatic neuroendocrine tumor liver metastases via abrogation of NFκB signaling

  Thursday, March 5, 2026
  4:37 PM - 4:44 PM MST

• P100. Continuous exposure to proteasome inhibition leads to increased cytotoxicity in colorectal liver metastases

  Saturday, March 7, 2026
  9:49 AM - 9:56 AM MST